Skip to content
★ Sign in to follow
TI

Touchstone International Medical Science Co., Ltd. Stock: price and insider trades · China

天臣医疗

CN·Mcap CN¥1.8BHealth Care

No insider purchase over the last 90 days. The latest, by 沈捷尔, was filed 27 Jan 2025.

Touchstone International Medical Science Co., Ltd.: what insiders have been doing

This page follows insider dealings at Touchstone International Medical Science Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. Between 4 November 2025 and 4 November 2026, 1 insider published 1 filing.

No insider bought on the market over the period, while 1 insider filed 1 sale totalling €53k. One trade stands out by size: a sale of €53k from 丁水澄, disclosed on 27 January 2026.

With 1 filing in twelve months, the company is quieter than the median of 2 filings across the 517 companies we follow on the same exchange. Since 2021, the database holds 1 purchase and 10 sales by insiders of the company.

Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.

Insider Decl.
11
Thresholds
n/a
Buy Volume
€39,577
1 ops. · all time
Sell Volume
€5M
10 ops. · all time

Who traded when

BuySale
丁水澄1 sale
沈捷尔1 buy

Since the insiders bought

  • Filed 27 Jan 2025 · 650 days ago · €40k
    +130.2%
    Entry CN¥18.86 · Close at T+365 CN¥43.42

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 8,954 of 26,914 companies
59.9
score / 100
Value
41
Quality
78
FCF yld-1.1%
Earn yld4.8%
EV/EBITDA16.9x
ROE9.5%
Gross mgn64%
Net mgn26%
Debt/EBITDA0.5x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥22.00
Analyst consensus
·
Income statement
RevenueCN¥326.7M
Gross profitCN¥208.9M64% margin
EBITDACN¥108.6M33% margin
Net incomeCN¥85.2M17.9% margin
Valuation
PER (trailing)34.9x
P/Book3.6x
Beta0.22
Balance sheet & cash
Market capCN¥1.8B
Total debtCN¥50.5M
Free Cash Flow-CN¥18.8M
Debt / Equity26%
Profitability & ownership
ROE9.5%
ROA4.1%
% insiders56.8%
% institutions3.2%
Last declaration on 27 January 2026
Declarations11 total
  • ▼
    核心技术人员Executives
    435,180 CNY6SSE
    10,000 shares38.5% of flowA股XSHGSSE:273000000154506720
  • ▲
    监事Executives
    300,128 CNY15SSE
    16,000 shares100.0% of flowA股XSHGSSE:173000008516010780
    Canonical exit: 27 Apr 2025 (T+90)
  • ▼
    核心技术人员Executives
    556,297 CNY8SSE
    29,004 shares62.0% of flowA股XSHGSSE:173000008214155360
  • ▼
    核心技术人员Executives
    44,940 CNY2SSE
    2,000 shares4.2% of flowA股XSHGSSE:173000006887283900
  • ▼
    核心技术人员Executives
    387,808 CNY18SSE
    16,000 shares37.2% of flowA股XSHGSSE:173000006636984700
  • ▼
    核心技术人员Executives
    49,560 CNY14SSE
    2,000 shares4.8% of flowA股XSHGSSE:173000006628061540
  • ▼
    核心技术人员Executives
    334,320 CNY18SSE
    14,000 shares38.0% of flowA股XSHGSSE:173000006614201800
  • ▼
    核心技术人员Executives
    159,691 CNY4SSE
    7,000 shares15.3% of flowA股XSHGSSE:173000006564492400
  • ▼
    董事Executives
    9M CNY10SSE
    497,600 shares27.2% of flowA股XSHGSSE:173000005908510430
  • ▼
    董事Executives
    10M CNY10SSE
    475,400 shares28.8% of flowA股XSHGSSE:173000005118839360
  • ▼
    董事Executives
    15M CNY11SSE
    699,400 shares44.0% of flowA股XSHGSSE:173000005109814620

11 of 11 declarations

About Touchstone International Medical Science Co., Ltd.

天臣医疗 is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative medical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations